Ameliorative Effect and Underlying Mechanisms of Total Triterpenoids from Psidium guajava Linn (Myrtaceae) Leaf on High-Fat Streptozotocin-induced Diabetic Peripheral Neuropathy in Rats

Xiaokang Wang, Kaihe Ye, Yanqing Lv, Songcheng Wei, Xiucun Li, Jinjin Ma, Xiaoqi Zhang, Chunling Ye
2016 Tropical Journal of Pharmaceutical Research  
Purpose: To investigate whether the total triterpenoids extracted from Psidium Guajava leaves (TTPGL) attenuate the development of diabetic peripheral neuropathy in rats by regulating the NF-κB pathway of the inflammatory process and its signaling mediators. Methods: All the Sprague Dawley rats used were maintained in a clean environment on a 12 h light/12 h dark cycle. High-fat feeding and intraperitoneal injection of 40 mg/kg streptozotocin (STZ) were used to induce diabetes in the rats. The
more » ... s in the rats. The rats were randomly divided into 5 groups: diabetic mellitus (DM) group; TTPGL -30 group, TTPGL -60 group and TTPGL -120 group treated by intragastric administration (i.g) with 30, 100 and 120 mg/kg/day TTPGL, respectively. The well-established drug, rosiglitazone (RSG, 3 mg/k/d, i.g.), was used as positive control. Normal rats served as control group. Nerve conduction velocity and sensitive tests were measured on weeks 1, 4 and 8. After 8 weeks administration, expression of pro-inflammatory molecules (TNFα, IL -6 and iNOS) and tissue proteins (Akt, IKKα, and NF -κB -p65) were evaluated to assess biochemical changes. Results: Compared to DM group, TTPGL (especially 120 mg / kg dose) treatment improved (p < 0.05) physical functions and provided neuronal protection in high -fat/streptozotocin -induced peripheral neuropathy rats. We found that the expressions of several pro -inflammatory factors such as tumor necrosis factorα (TNFα), IL -6 and inducible nitric oxide synthase (iNOS) were highly suppressed (p < 0.05 or p < 0.01) by TTPGL in sciatic nerve. Mechanism analysis indicated that the ameliorative effect of TTPGL, in part, is through suppression of the expression of pro -inflammatory cytokines by NF -κB pathway mediation. Conclusion: TTPGL offers a potential therapeutic approach for the treatment of diabetic peripheral neuropathy.
doi:10.4314/tjpr.v15i2.15 fatcat:f5y3thozf5dphhabvgtfloa2ke